Bibliography
Filters: First Letter Of Title is A [Clear All Filters]
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
An alternative to the hand searching gold standard: validating methodological search filters using relative recall. BMC Med Res Methodol. 2006;6:33. Abstract
Analysis of the reporting of search strategies in Cochrane systematic reviews. J Med Libr Assoc. 2009;97(1):21-9. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care. 2013;29(3):282-9. Abstract
Appraisal of Guidelines for Research & Evaluation II. AGREE Research Trust; 2009. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Australia - GHO Country statistics. Vol 2014. Geneva: World Health Organisation (WHO); 2014. Abstract
Australia: Health System Review. Vol 8 (5). Copenhagen: WHO Regional Office for Europe; 2006.
Australian supermodel?--A practical example of evidence-based library and information practice (EBLIP). Health Info Libr J. 2006;23(1):69-72.
Assessing the impact of health technology assessment on the austrian healthcare system. Int J Technol Assess Health Care. 2013;29(1):84-91. Abstract
Austria: Health system review. Vol 8 (3). Copenhagen: WHO Regional Office for Europe; 2006.
Austria: history of health technology assessment during the past 20 years. Int J Technol Assess Health Care. 2009;25 Suppl 1:74-81. Abstract
Analysis of the reporting of search strategies in Cochrane systematic reviews. J Med Libr Assoc. 2009;97(1):21-9. Abstract
American College of Physicians Ethics Manual: sixth edition. Ann Intern Med. 2012;156(1 Pt 2):73-104. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Access with Evidence Development. HTAi Interest Sub-Group on Conditional Coverage and Evidence Development for Promising Technologies; 2010. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Assessing genetic testing: who are the "lay experts"? Health Policy. 2008;85(1):1-18. Abstract
Assessing the impacts of citizen deliberations on the health technology process. Int J Technol Assess Health Care. 2013;29(3):282-9. Abstract
A-4, a bis tertiary amine derivative of hemicholinium-3 produces in vivo reduction of acetylcholine in rat brain regions. J Pharmacol Exp Ther. 1987;240(2):476-85. Abstract
Assessing the impact of health technology assessment in The Netherlands. Int J Technol Assess Health Care. 2008;24(3):259-69. Abstract